MX393928B - Composiciones alergénicas mixtas y métodos de uso de las mismas. - Google Patents

Composiciones alergénicas mixtas y métodos de uso de las mismas.

Info

Publication number
MX393928B
MX393928B MX2017010697A MX2017010697A MX393928B MX 393928 B MX393928 B MX 393928B MX 2017010697 A MX2017010697 A MX 2017010697A MX 2017010697 A MX2017010697 A MX 2017010697A MX 393928 B MX393928 B MX 393928B
Authority
MX
Mexico
Prior art keywords
mixed
allergen
compositions
methods
nut
Prior art date
Application number
MX2017010697A
Other languages
English (en)
Other versions
MX2017010697A (es
Inventor
Kari C Nadeau
Original Assignee
Univ Leland Stanford Junior
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=56689334&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX393928(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Univ Leland Stanford Junior filed Critical Univ Leland Stanford Junior
Publication of MX2017010697A publication Critical patent/MX2017010697A/es
Publication of MX393928B publication Critical patent/MX393928B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/35—Allergens
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/60—Fish, e.g. seahorses; Fish eggs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/35—Allergens
    • A61K39/36—Allergens from pollen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11—Medicinal preparations comprising living procariotic cells
    • A61K2035/115—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A61K2039/572—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 cytotoxic response
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A61K2039/575—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 humoral response
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Pulmonology (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Botany (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Seeds, Soups, And Other Foods (AREA)

Abstract

La presente invención se refiere a una composición alergénica mixta, caracterizada porque comprende; un alérgeno de nuez seleccionado del grupo que consiste de un alérgeno de cacahuate, un alérgeno de almendra, un alérgeno de nuez de Castilla, un alérgeno de nuez de la India, un alérgeno de avellana, un alérgeno de pacana y un alérgeno de pistache; un alérgeno de animal seleccionado del grupo que consiste de un alérgeno de camarón un alérgeno de bacalao, y un alérgeno de salmón; y por lo menos uno de; un alérgeno de planta diferente de nuez; un agente biótico; y una vitamina, en donde la composición comprende partes en peso del alérgeno de nuez, el alérgeno de animal, y el alérgeno de planta diferente de nuez, si está presente.
MX2017010697A 2015-02-20 2016-02-19 Composiciones alergénicas mixtas y métodos de uso de las mismas. MX393928B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562119014P 2015-02-20 2015-02-20
PCT/US2016/018731 WO2016134291A2 (en) 2015-02-20 2016-02-19 Mixed allergen compositions and methods for using the same

Publications (2)

Publication Number Publication Date
MX2017010697A MX2017010697A (es) 2017-11-17
MX393928B true MX393928B (es) 2025-03-24

Family

ID=56689334

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2017010697A MX393928B (es) 2015-02-20 2016-02-19 Composiciones alergénicas mixtas y métodos de uso de las mismas.
MX2022008663A MX2022008663A (es) 2015-02-20 2017-08-18 Composiciones alergenicas mixtas y metodos de uso de las mismas.

Family Applications After (1)

Application Number Title Priority Date Filing Date
MX2022008663A MX2022008663A (es) 2015-02-20 2017-08-18 Composiciones alergenicas mixtas y metodos de uso de las mismas.

Country Status (21)

Country Link
US (4) US10064936B2 (es)
EP (2) EP4186521A1 (es)
JP (3) JP6859261B2 (es)
KR (2) KR20170117562A (es)
CN (2) CN114129720B (es)
AU (2) AU2016219793C1 (es)
CA (1) CA2977127A1 (es)
DK (1) DK3258962T3 (es)
ES (1) ES2937287T3 (es)
FI (1) FI3258962T3 (es)
HU (1) HUE061576T2 (es)
IL (1) IL253976B2 (es)
LT (1) LT3258962T (es)
MA (1) MA41558B1 (es)
MX (2) MX393928B (es)
PL (1) PL3258962T3 (es)
PT (1) PT3258962T (es)
RS (1) RS63941B1 (es)
SG (2) SG11201706734SA (es)
SI (1) SI3258962T1 (es)
WO (1) WO2016134291A2 (es)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10149904B2 (en) 2015-02-20 2018-12-11 The Board Of Trusteees Of The Leland Stanford Junior University Mixed allergen compositions and methods for using the same
US10143742B2 (en) * 2015-02-20 2018-12-04 The Board Of Trustees Of The Leland Stanford Junior University Mixed allergen compositions and methods for using the same
US10166286B2 (en) 2015-02-20 2019-01-01 The Board Of Trustees Of The Leland Stanford Junior University Mixed allergen compositions and methods for using the same
US11452774B2 (en) 2015-02-20 2022-09-27 The Board Of Trustees Of The Leland Stanford Junior University Mixed allergen compositions and methods for using the same
CA2977127A1 (en) 2015-02-20 2016-08-25 The Board Of Trustees Of The Leland Stanford Junior University Mixed allergen compositions and methods for using the same
US20160263212A1 (en) * 2015-02-23 2016-09-15 Antera Therapeutics Inc. Compositions and methods for tolerizing the immune system to allergens
US10856567B2 (en) 2016-07-22 2020-12-08 Kari Brown Baby food products containing allergenic proteins and methods of delivering same
WO2018094390A1 (en) * 2016-11-21 2018-05-24 Before Brands, Inc. Liquid allergen compositions and methods for making the same
US10656145B2 (en) 2016-12-09 2020-05-19 General Mills, Inc. Detection of allergens using surface-enhanced raman scattering
AU2018207167A1 (en) * 2017-01-13 2019-07-25 Societe Des Produits Nestle S.A. Methods of manufacture of nut flours and formulations for oral immunotherapy
FR3062797B1 (fr) * 2017-02-10 2025-03-07 Centre Hospitalier Et Univ De Clermont Ferrand Gelule a liberation gastro-intestinale destinee a etre utilisee dans une methode permettant de desensibiliser et/ou d'induire une tolerance chez un sujet allergique a l'arachide
US20180360951A1 (en) * 2017-06-20 2018-12-20 Evros Vassiliou Method, composition & apparatus for the treatment of type i allergic hypersensitivities by immune desensitization through slit immunotherapy with unadulterated allergen, vitamin a and vitamin d
EP3654778A1 (en) 2017-07-18 2020-05-27 Before Brands, Inc. Methods for making mixed allergen compositions
EP4545077A1 (en) 2017-12-06 2025-04-30 Prollergy Corporation Composition and method for reducing allergic response
EP3836801A4 (en) * 2018-08-16 2022-05-18 Société des Produits Nestlé S.A. MAINTENANCE DOSE ORAL PEANUT IMMUNOTHERAPY
US20220016238A1 (en) * 2018-11-30 2022-01-20 Alladapt Immunotherapeutics, Inc. Methods for making mixed allergen compositions
JP2022514642A (ja) * 2018-12-21 2022-02-14 ソシエテ・デ・プロデュイ・ネスレ・エス・アー 乳児用飲用組成物
WO2020146781A1 (en) * 2019-01-10 2020-07-16 Before Brands, Inc. Methods of introducing food allergens
CN113507844A (zh) 2019-01-23 2021-10-15 前品牌股份有限公司 制备混合型过敏原组合物的方法
US20200236982A1 (en) * 2019-01-28 2020-07-30 Lil Mixins, Llc Tree nut powder formulation
US11154082B2 (en) 2019-06-13 2021-10-26 Lil Mixins, Llc Egg product for infants and babies and method of making same
US11324247B2 (en) 2019-06-13 2022-05-10 Lil Mixins, Llc Food products for infants and babies and method of making same
US20240151702A1 (en) * 2021-03-05 2024-05-09 Societe Des Produits Nestle S.A. Methods of making and assessing allergenic tree nut compositions
US11154081B1 (en) 2021-03-16 2021-10-26 Lil Mixins, Llc Well cooked egg powder
US11439173B1 (en) 2021-09-22 2022-09-13 Lil Mixins, Llc Low allergenicity well cooked food powder
CN117088950B (zh) * 2023-04-11 2025-02-07 西北农林科技大学 一种核桃低敏性复合物蛋白、制备方法及应用
CN117678739A (zh) * 2023-12-21 2024-03-12 唐楠 一种食物过敏原混合物及其制备方法和使用方法
KR102828054B1 (ko) * 2025-01-20 2025-07-01 최여름 이유식 첨가형 알러지 확인용 조성물

Family Cites Families (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4031199A (en) 1972-12-11 1977-06-21 Merck Patent Gesellschaft Mit Beschrankter Haftung Process for the production of allergen-containing extracts
US4166452A (en) 1976-05-03 1979-09-04 Generales Constantine D J Jr Apparatus for testing human responses to stimuli
US4256108A (en) 1977-04-07 1981-03-17 Alza Corporation Microporous-semipermeable laminated osmotic system
US4265874A (en) 1980-04-25 1981-05-05 Alza Corporation Method of delivering drug with aid of effervescent activity generated in environment of use
GB9323483D0 (en) 1993-11-13 1994-01-05 Cerestar Holding Bv Edible composition and a process for its preparation
AU2065801A (en) 1999-12-06 2001-06-12 Panacea Pharmaceuticals, Llc Passive desensitization
AU2001263073A1 (en) 2000-05-12 2001-11-26 Sigmund Kramer Peanut powder compositions and methods of making same
FR2822709B1 (fr) 2001-03-30 2007-01-19 Antialis Composition pharmaceutique anti-allergique comprenant au moins un allergene et au moins un compose antihistaminique
ATE503494T1 (de) 2003-06-23 2011-04-15 Biotech Tools Sa Epitop-zusammensetzung zur enterischen verabreichung hergestellt durch hydrolyse von antigenen strukturen mit chymotrypsin
US7595081B1 (en) 2003-10-17 2009-09-29 Bellar Willis F Non-flour containing baked and related food compositions
WO2005077410A1 (en) 2004-02-06 2005-08-25 Greer Laboratories, Inc. Methods and compositions for dosing of allergens
BRPI0710963A2 (pt) * 2006-02-27 2012-02-28 South Georgia Pecan Company Composição alimentícia para animais que compreende casca de noz
EP1872792A1 (en) 2006-06-29 2008-01-02 Biotech Tools S.A. A method for the production of hydrolyzed allergen
CN101646418B (zh) * 2006-10-12 2013-07-17 昆士兰大学 调节免疫应答的组合物和方法
US8709413B2 (en) 2006-12-13 2014-04-29 Michael R. Simon Treatment of celiac disease with IgA
US20100278880A1 (en) 2008-01-02 2010-11-04 Biotech Tools S.A. Pharmaceutical formulation for allergen preparation
ES2585407T3 (es) 2008-02-01 2016-10-05 Murdoch Childrens Research Institute Un método para inducir tolerancia a un alérgeno
EP2140880B1 (en) 2008-07-04 2012-11-14 HAL Allergy Holding B.V. Modification of allergens
US8802056B2 (en) 2008-07-17 2014-08-12 John Shea Method for testing and treating delayed food allergies
JP5805363B2 (ja) 2009-06-26 2015-11-04 和興フィルタテクノロジー株式会社 可溶性凝集体、免疫寛容誘導剤及びその製造方法
IN2012DN00878A (es) * 2009-08-18 2015-05-22 Nestec Sa
AU2010291171B2 (en) * 2009-09-07 2015-10-29 Dbv Technologies Method of treating eosinophilic esophagitis
CN102048077A (zh) * 2009-10-30 2011-05-11 梁振 一种方便营养果丁豆花
WO2011137422A2 (en) * 2010-04-30 2011-11-03 Apellis Pharmaceuticals, Inc. Methods and articles for preventing or reducing risk of developing a hyperallergenic immune system
US9271899B2 (en) 2010-04-30 2016-03-01 Allovate, Llc Methods, articles and kits for allergic desensitization, via the oral mucosa
GB201009368D0 (en) 2010-06-04 2010-07-21 Sana Pharma As Dietary formulations
BR112013009068A2 (pt) 2010-10-15 2016-07-19 Alk Abelló As supressão de uma resposta imune de hipersensibilidade com antígeno não relacionado derivado de material fonte de alérgeno
GB201104537D0 (en) * 2011-03-17 2011-05-04 Cambridge Entpr Ltd Treatment for peanut allergy
CN102986802A (zh) 2012-12-11 2013-03-27 崔杰 一种花生核桃咸饼的制作方法
EP3482771B1 (en) 2013-03-14 2023-01-18 Société des Produits Nestlé S.A. Manufacture of peanut formulations for oral desensitization
US9492535B2 (en) 2013-03-14 2016-11-15 Aimmune Therapeutics, Inc. Peanut formulations and uses thereof
CN105120898A (zh) 2013-03-19 2015-12-02 生物技术工具公司 过敏原制剂
HK1223019A1 (zh) 2013-06-06 2017-07-21 Anergis Sa 用於治疗室内尘蟎过敏的连续重叠肽
WO2015042402A1 (en) 2013-09-19 2015-03-26 Allovate, Llc Toothpaste for delivering allergens to oral mucosa
EP2952200A1 (en) 2014-06-04 2015-12-09 Alk-Abelló A/S Allergen for prophylactic treatment of allergy
CN106535931A (zh) 2014-08-25 2017-03-22 艾慕恩治疗公司 卵蛋白制剂及其制备方法
CN104273238A (zh) 2014-09-27 2015-01-14 合肥市凤落河豆制食品有限公司 一种芝麻酱干及其制备方法
US11452774B2 (en) * 2015-02-20 2022-09-27 The Board Of Trustees Of The Leland Stanford Junior University Mixed allergen compositions and methods for using the same
CA2977127A1 (en) * 2015-02-20 2016-08-25 The Board Of Trustees Of The Leland Stanford Junior University Mixed allergen compositions and methods for using the same
US10149904B2 (en) * 2015-02-20 2018-12-11 The Board Of Trusteees Of The Leland Stanford Junior University Mixed allergen compositions and methods for using the same
US10166286B2 (en) * 2015-02-20 2019-01-01 The Board Of Trustees Of The Leland Stanford Junior University Mixed allergen compositions and methods for using the same
US20160263212A1 (en) 2015-02-23 2016-09-15 Antera Therapeutics Inc. Compositions and methods for tolerizing the immune system to allergens

Also Published As

Publication number Publication date
CN107405394B (zh) 2021-12-14
EP3258962A2 (en) 2017-12-27
FI3258962T3 (fi) 2023-04-12
WO2016134291A2 (en) 2016-08-25
MA41558A (fr) 2017-12-26
US20170056494A1 (en) 2017-03-02
SI3258962T1 (sl) 2023-07-31
IL253976A0 (en) 2017-10-31
LT3258962T (lt) 2023-02-27
US9731003B2 (en) 2017-08-15
EP4186521A1 (en) 2023-05-31
US10064936B2 (en) 2018-09-04
HUE061576T2 (hu) 2023-07-28
AU2022201699B2 (en) 2025-04-10
CA2977127A1 (en) 2016-08-25
EP3258962B1 (en) 2022-11-02
SG10201909093XA (en) 2019-11-28
MX2017010697A (es) 2017-11-17
KR20240148968A (ko) 2024-10-11
PT3258962T (pt) 2023-02-16
ES2937287T3 (es) 2023-03-27
CN114129720A (zh) 2022-03-04
SG11201706734SA (en) 2017-09-28
MA41558B1 (fr) 2023-02-28
RS63941B1 (sr) 2023-02-28
BR112017017894A2 (pt) 2018-04-10
JP2022125346A (ja) 2022-08-26
AU2022201699A1 (en) 2022-04-07
WO2016134291A3 (en) 2016-10-13
PL3258962T3 (pl) 2023-04-24
JP2021046445A (ja) 2021-03-25
JP6859261B2 (ja) 2021-04-14
US20220133882A1 (en) 2022-05-05
JP2018505907A (ja) 2018-03-01
US20160243217A1 (en) 2016-08-25
CN114129720B (zh) 2025-01-07
AU2016219793A1 (en) 2017-08-31
KR20170117562A (ko) 2017-10-23
US20190038741A1 (en) 2019-02-07
IL253976B1 (en) 2024-05-01
AU2016219793C1 (en) 2022-03-17
EP3258962A4 (en) 2018-07-11
AU2016219793B2 (en) 2021-12-16
HK1247854A1 (en) 2018-10-05
JP7509829B2 (ja) 2024-07-02
IL253976B2 (en) 2024-09-01
NZ734525A (en) 2024-11-29
MX2022008663A (es) 2022-08-10
CN107405394A (zh) 2017-11-28
DK3258962T3 (da) 2023-02-06

Similar Documents

Publication Publication Date Title
MX393928B (es) Composiciones alergénicas mixtas y métodos de uso de las mismas.
CY1120529T1 (el) Προφαρμακα φουμαρικων αλατων και η χρηση τους στην αγωγη ποικιλων νοσων
CL2018000320A1 (es) Coadyuvantes basados en aceite (divisional de solicitud 201600650)
PL3896064T3 (pl) Pochodne 4,6-diamino-chinolino-3-karbonitrylu jako modulatory cot w leczeniu choroby leśniowskiego-crohna i wrzodziejącego zapalenia jelita grubego
MX377340B (es) Composiciones en solución sólida y uso en el tratamiento de enfermedades cardiovasculares.
CR20190063A (es) 3-metil pirazinas 2,5-disustituídas y 3-metil pirazinas 2,5,6-trisustituídas como inhibidores alostéricos de shp2
MX2019015311A (es) Composiciones de ésteres de ácido cannabidiólico y usos de las mismas.
EP4620520A3 (en) Methods and compositions relating to chondrisomes
MX386752B (es) Agonistas del receptor farnesoide x y usos de los mismos.
WO2014176128A3 (en) Compositions and methods for the therapy and diagnosis of influenza
WO2016060996A3 (en) Interleukin-15 compositions and uses thereof
MX2015003140A (es) Formulaciones de enzalutamida.
EP3337465A4 (en) Compositions and methods of use in combination for the treatment and diagnosis of autoimmune diseases
EP3378861A4 (en) ACRYLIC ACID DERIVATIVE, METHOD OF MANUFACTURE AND USE THEREOF IN MEDICINE
SG10201808104RA (en) Cenicriviroc for the treatment of fibrosis
EA201790787A1 (ru) Снижение вязкости фармацевтических составов
MX384802B (es) Composicion que contiene quitina y proteinas digeribles.
MX392199B (es) Composiciones farmaceuticas para terapia de combinacion
AR106644A1 (es) Composiciones nutricionales sinergísticas y usos de las mismas
CL2015000039A1 (es) Derivados estra-1,3,5(10),16-tetraeno-3-sustituidos, preparaciones farmacéuticas que los comprenden y su uso en la preparación de medicamentos para tratar la endometriosis.
BR112016013800A2 (pt) Composições e métodos para reduzir alérgenos de gatos no ambiente
MX390126B (es) Nuevas isoformas de tripsina y su uso.
MX379359B (es) Derivados de 8-amino-2-oxo-1,3-diaza-espiro-[4.5]-decano.
MX364800B (es) Tilmicosina de accion prolongada mejorada y el uso de la misma en el tratamiento del complejo respiratorio bovino (crb) y en el periodo de la vaca seca.
IL253500B (en) Extracts of edible fungi enriched in vitamin d and compositions thereof and their use in the treatment of immune-related disorders